Creating the conditions for universal access to new Hepatitis C treatments
Since 2014, the introduction of new Direct-Acting Antiviral (DAA) drugs has considerably changed the way hepatitis C infections are treated...
Since 2014, the introduction of new Direct-Acting Antiviral (DAA) drugs has considerably changed the way hepatitis C infections are treated...
The French Presidency of the G20 has put the issue of innovative financing on the agenda for the summit which will start on 3 November in Cannes. For the past Lire la suite
Last December, in accordance with the World Trade Organisation (WTO) agreement on the aspects of the intellectual property rights related to trade and the Doha statement to the public health, Lire la suite
In the past month, three foreign national patients were sent back to their countries of origin despite the fact that public health inspection doctors issued statements objecting to this procedure. Lire la suite
Members of the International Committee: François Bourdillon; Samir Hamamah; Danièle Juette; Chantal Lebatard; Claude Le Pen; William Lowenstein; Marc de Montalembert; Jean-Luc Romero; Willy Rozenbaum, President; Muriel Vray. Report produced Lire la suite
On 14 June 2005, the CNS handed down an opinion about the human resources crisis in the Southern countries, based on a report by the international commission, entitled, «The Human Lire la suite
Commission Leader: Mr. Willy Rozenbaum Commission Members: Mr. Didier Fassin Mr. Jacques Gradt Mrs. Chantal Lebatard Mr. William Lowenstein Mrs. Véronique Nahoum-Grappe Rapporteurs: Mr. Marc Dixneuf, Mr. Anthony Poncier